High-Throughput Automated Microscopy of Circulating Tumor Cells

Circulating tumor cells (CTCs) have the potential of becoming the gold standard marker for cancer diagnosis, prognosis and monitoring. However, current methods for its isolation and characterization suffer from equipment variability and human operator error that hinder its widespread use. Here we report the design and construction of a fully automated high-throughput fluorescence microscope that enables the imaging and classification of cancer cells that were labeled by immunostaining procedures. An excellent agreement between our machine vision-based approach and a state-of-the-art microscopy equipment was achieved. Our integral approach provides a path for operator-free and robust analysis of cancer cells as a standard clinical practice.

[1]  Chwee Teck Lim,et al.  Versatile label free biochip for the detection of circulating tumor cells from peripheral blood in cancer patients. , 2010, Biosensors & bioelectronics.

[2]  Mehmet Toner,et al.  Circulating tumor cells: approaches to isolation and characterization , 2011, The Journal of cell biology.

[3]  D. Haber,et al.  Circulating tumor cells: a window into cancer biology and metastasis. , 2010, Current opinion in genetics & development.

[4]  Chang Li,et al.  Analysis of Circulating Tumor Cells in Ovarian Cancer and Their Clinical Value as a Biomarker , 2018, Cellular Physiology and Biochemistry.

[5]  S. Digumarthy,et al.  Isolation of rare circulating tumour cells in cancer patients by microchip technology , 2007, Nature.

[6]  K. Pantel,et al.  Challenges in circulating tumour cell research , 2014, Nature Reviews Cancer.

[7]  W. Heston,et al.  Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer , 2004, Journal of cellular biochemistry.

[8]  G. Doyle,et al.  Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer , 2009, Journal of oncology.

[9]  Kazunori Hoshino,et al.  Microchip-based immunomagnetic detection of circulating tumor cells. , 2011, Lab on a chip.

[10]  D. Lorente,et al.  Circulating tumour cell increase as a biomarker of disease progression in metastatic castration-resistant prostate cancer patients with low baseline CTC counts , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  Ying-Chih Chang,et al.  Circulating Tumor Cell Count Correlates with Colorectal Neoplasm Progression and Is a Prognostic Marker for Distant Metastasis in Non-Metastatic Patients , 2016, Scientific Reports.

[12]  Carlota Costa,et al.  CK-coated magnetic-based beads as a tool to isolate circulating tumor cells (CTCs) in human tumors. , 2013, Translational lung cancer research.

[13]  Leon W.M.M. Terstappen,et al.  Circulating Tumor Cells versus Imaging—Predicting Overall Survival in Metastatic Breast Cancer , 2006, Clinical Cancer Research.

[14]  Neal J Meropol,et al.  Circulating tumor cells: evolving evidence and future challenges. , 2009, The oncologist.

[15]  Matteo Brunelli,et al.  Circulating Tumor Cells: A Reliable Biomarker for Prostate Cancer Treatment Assessment? , 2017, Current drug metabolism.

[16]  Sebastian Chakrit Bhakdi,et al.  Easy Employment and Crosstalk-Free Detection of Seven Fluorophores in a Widefield Fluorescence Microscope , 2018, Methods and protocols.

[17]  Klaus Pantel,et al.  [The circulating tumor cells: liquid biopsy of cancer]. , 2014, Klinicheskaia laboratornaia diagnostika.

[18]  Johannes E. Schindelin,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[19]  J S de Bono,et al.  Statin use and outcome in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated in the TROPIC trial. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[20]  Bruce Montgomery,et al.  AR-Variant–Positive CTC: A Surrogate for a Surrogate for Taxane Therapy Outcome? , 2018, Clinical Cancer Research.

[21]  Tomoko Yoshino,et al.  Size-selective microcavity array for rapid and efficient detection of circulating tumor cells. , 2010, Analytical chemistry.

[22]  K. Isselbacher,et al.  Isolation of circulating tumor cells using a microvortex-generating herringbone-chip , 2010, Proceedings of the National Academy of Sciences.

[23]  N. Otsu A threshold selection method from gray level histograms , 1979 .

[24]  Tanja Fehm,et al.  Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer , 2016, Clinical Cancer Research.

[25]  I. Fidler,et al.  The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.

[26]  Ali Asgar S. Bhagat,et al.  Clinical Validation of an Ultra High-Throughput Spiral Microfluidics for the Detection and Enrichment of Viable Circulating Tumor Cells , 2014, PloS one.

[27]  A. Chambers,et al.  Detection and quantification of circulating tumor cells in mouse models of human breast cancer using immunomagnetic enrichment and multiparameter flow cytometry , 2005, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[28]  Leon W M M Terstappen,et al.  Circulating tumor cells before and during follow-up after breast cancer surgery. , 2015, International journal of oncology.

[29]  Rajan P Kulkarni,et al.  Size-selective collection of circulating tumor cells using Vortex technology. , 2014, Lab on a chip.

[30]  Donald E Ingber,et al.  A combined micromagnetic-microfluidic device for rapid capture and culture of rare circulating tumor cells. , 2012, Lab on a chip.

[31]  Jonathan W. Uhr,et al.  Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases , 2004, Clinical Cancer Research.

[32]  Paraskevi Giannakakou,et al.  Functional Characterization of Circulating Tumor Cells with a Prostate-Cancer-Specific Microfluidic Device , 2012, PloS one.

[33]  L. Terstappen,et al.  Towards the Biological Understanding of CTC: Capture Technologies, Definitions and Potential to Create Metastasis , 2013, Cancers.

[34]  Erik Meijering,et al.  Imagining the future of bioimage analysis , 2016, Nature Biotechnology.

[35]  G. Raj,et al.  Blur image detection using Laplacian operator and Open-CV , 2016, 2016 International Conference System Modeling & Advancement in Research Trends (SMART).

[36]  Chunsheng Jiang,et al.  Quest for the Ideal Cancer Biomarker: An Update on Progress in Capture and Characterization of Circulating Tumor Cells , 2013 .

[37]  George Poste,et al.  The "seed and soil" hypothesis revisited. , 2008, The Lancet. Oncology.

[38]  Mehmet Toner,et al.  Isolation and Characterization of Circulating Tumor Cells from Patients with Localized and Metastatic Prostate Cancer , 2010, Science Translational Medicine.

[39]  Jochen K. Lennerz,et al.  Detecting predictive androgen receptor modifications in circulating prostate cancer cells , 2015, Oncotarget.

[40]  M. Alunni-Fabbroni,et al.  Circulating tumour cells in clinical practice: Methods of detection and possible characterization. , 2010, Methods.